BORA PHARMACEUTICALS LTD

Price Chart

Risk-Adjusted Performance

Also Listed On

BORA PHARMACEUTICALS LTD (6472) Price Performance

BORA PHARMACEUTICALS LTD (6472) trades on TW in TWD. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at TWD416.50, up 0.12% from the previous close.

Over the past year, 6472 has traded between a low of TWD402.50 and a high of TWD792.00. The stock has lost 22.1% over this period. It is currently 47.4% below its 52-week high.

BORA PHARMACEUTICALS LTD has a market capitalization of $54.17B, with a price-to-earnings ratio of 12.68 and a dividend yield of 2.35%.

About BORA PHARMACEUTICALS LTD

Bora Pharmaceuticals Co., LTD. engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally. The company operates through Sales, CDMO, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services and technical services for the development of pharmaceutical products. In addition, it provides Western pharmaceuticals, including central nervous system medications, antibiotics, and gastrointestinal medications; and nutritional and vitamin supplements, physical recovery, and health care products. The company sells its products directly to clinics, pharmacies, pharmacy chains, and drug stores, as well as through distributors to medical centers, corporate and public hospitals, and regional and district hospitals. Bora Pharmaceuticals Co., LTD. was incorporated in 2007 and is based in Taipei City, Taiwan.

Compare BORA PHARMACEUTICALS LTD

Side-by-side comparison against top Healthcare peers.